Navigation Links
Blood Test Might Spot Pancreatic Cancer Early, Study Finds
Date:3/29/2013

By Steven Reinberg
HealthDay Reporter

FRIDAY, March 29 (HealthDay News) -- A new blood test that detects deadly pancreatic cancer earlier than usual might slightly improve patients' odds for survival, a small Japanese study suggests.

"This new diagnostic test may be a safe and easy screening method that could improve the prognosis of patients with pancreatic cancer through earlier detection," said lead researcher Dr. Masaru Yoshida, an associate professor in the division of metabolomics research at Kobe University Graduate School of Medicine. "A drop of blood contains a lot of information."

Currently, the 5-year survival rate for pancreatic cancer is less than 5 percent, largely because the cancer usually has spread by the time it is detected.

The new approach relies on metabolomics technology, an emerging science that focuses on small molecules. The blood test measures byproducts of metabolism, called metabolites, found in the blood.

By looking for differences between the levels of metabolites in patients with and without pancreatic cancer, the researchers are able to identify those with cancer.

Finding pancreatic cancer earlier means more patients can have the tumor removed and live longer than most patients do now, Yoshida noted.

"Conventional tests using blood or imaging are not appropriate for pancreatic cancer screening and early detection, so new screening and diagnostic methods for pancreatic cancer are urgently required," Yoshida said.

Currently, in more than 80 percent of cases of pancreatic cancer, the cancer has metastasized, or spread, making it inoperable, he explained.

One expert doesn't think this test is a breakthrough.

"It's an improvement, but not a breakthrough," said Dr. James D'Olimpio, director of supportive oncology at North Shore-LIJ Cancer Institute in Lake Success, N.Y.

"The problem is it's not early enough," he said.

Even if the cancerous tumor can be removed, it's usually too late, he said. By the time the cancer is detected, even in the early stage suggested by their test, the cancer has most likely spread beyond the pancreas, D'Olimpio pointed out.

"The test is able to detect cancer when it is at stage 1, but it's a fatal disease once it gets past stage 0," D'Olimpio said. (Staging, which refers to the severity of a person's cancer, usually runs from 0 to 4.)

"The cure rates of these patients is still going to be less than 20 percent," he said.

For the study, published online March 29 in Cancer Epidemiology, Biomarkers & Prevention, the researchers used a technology called gas chromatography mass spectrometry to analyze the blood from study participants.

The researchers randomly assigned 43 pancreatic cancer patients and 42 healthy participants to what they called a training set, where they made their initial findings. To validate their findings, they also tried the test on 42 patients with pancreatic cancer, 41 healthy people and 23 people with chronic pancreatitis (inflammation of the pancreas).

The researchers found 18 metabolites that were significantly different in patients with pancreatic cancer, compared with the healthy patients.

They refined their test using four metabolites to identify patients with pancreatic cancer.

The test had a sensitivity of 71.4 percent and a specificity of 78.1 percent when it was used with patients with pancreatic cancer and patients with chronic pancreatitis, the researchers reported. Sensitivity measures the accuracy of the test in identifying people with pancreatic cancer and specificity measures the accuracy of the test in weeding out those who didn't have the disease. Chronic pancreatitis is sometimes mistaken for cancer, so cutting down false positives is important.

More information

For more information on pancreatic cancer, visit the American Cancer Society.

SOURCES: Masaru Yoshida M.D., Ph.D., associate professor, division of metabolomics research, Kobe University Graduate School of Medicine, Japan; James D'Olimpio, M.D., director, Supportive Oncology and the Palliative Care/Cancer Pain Center, North Shore-LIJ Cancer Institute, Lake Success, N.Y.; March 29, 2013, Cancer Epidemiology, Biomarkers & Prevention, online


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. OneBlood Partners with BloodHub for Supply Chain Automation
2. Online Program developed by Professional Nutrition Therapists Offers Hope to Millions for Getting Blood Sugars under Control Right from the Comfort of Home
3. GW professor researching ways to improve human tissue dissection, reduce blood transfusions
4. Researchers decode biology of blood and iron disorders mapping out novel future therapies
5. Reversing blood and freshening it up
6. Diet Can Lower Blood Pressure As Much As Taking A Medication, From The March 2013 Harvard Men's Health Watch
7. NuvaRing Blood-Clotting Claims Now Being Investigated by Resource4thePeople Attorneys
8. New method developed to expand blood stem cells for bone marrow transplant
9. Blacks More Likely to Get Amputations Due to Blocked Blood Flow: Study
10. UC Davis research advances efforts to prevent dangerous blood clots
11. PCL Alverno Laboratories Launches Blood Test to Aid in the Early Detection of Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Test Might Spot Pancreatic Cancer Early, Study Finds
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
Breaking Medicine Technology: